CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Amedisys - AMED CFD

    Market is not available at the moment

    Market information is presented
    as of 2023-09-21

    • Summary
    Trading Conditions
    Spread 0.23
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026151 %
    Charges from full value of position ($-4.97)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026151%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003929 %
    Charges from full value of position ($0.75)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003929%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Amedisys Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 109.56
    Open* 109.3
    1-Year Change* -0.65%
    Day's Range* 106.57 - 111.92
    52 wk Range 69.37-126.81
    Average Volume (10 days) 579.14K
    Average Volume (3 months) 9.52M
    Market Cap 3.03B
    P/E Ratio 1,341.17
    Shares Outstanding 32.63M
    Revenue 2.23B
    EPS 0.07
    Dividend (Yield %) N/A
    Beta 1.00
    Next Earnings Date Oct 24, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    Date Close Change Change (%) Open High Low
    Jun 29, 2022 109.98 0.67 0.61% 109.31 112.01 106.23
    Jun 28, 2022 109.56 -3.02 -2.68% 112.58 114.45 109.51
    Jun 27, 2022 114.51 -2.68 -2.29% 117.19 117.59 111.22
    Jun 24, 2022 115.50 4.81 4.35% 110.69 116.12 110.41
    Jun 23, 2022 115.18 6.07 5.56% 109.11 115.42 107.94
    Jun 22, 2022 108.44 1.67 1.56% 106.77 111.76 106.13
    Jun 21, 2022 107.29 -2.66 -2.42% 109.95 109.95 101.37
    Jun 17, 2022 121.29 6.53 5.69% 114.76 122.49 114.76
    Jun 16, 2022 115.50 5.49 4.99% 110.01 116.23 110.01
    Jun 15, 2022 115.84 6.59 6.03% 109.25 117.57 109.25
    Jun 14, 2022 110.93 0.43 0.39% 110.50 112.49 109.22
    Jun 13, 2022 111.44 -0.48 -0.43% 111.92 118.67 110.64
    Jun 10, 2022 119.95 7.51 6.68% 112.44 120.29 112.42
    Jun 9, 2022 114.91 4.56 4.13% 110.35 115.90 110.35
    Jun 8, 2022 115.53 0.50 0.43% 115.03 118.23 114.28
    Jun 7, 2022 115.06 2.40 2.13% 112.66 115.98 111.04
    Jun 6, 2022 114.59 -0.59 -0.51% 115.18 117.76 114.09
    Jun 3, 2022 115.04 1.82 1.61% 113.22 115.66 112.80
    Jun 2, 2022 116.10 0.76 0.66% 115.34 117.20 113.67
    Jun 1, 2022 115.48 -0.59 -0.51% 116.07 117.85 113.76

    Amedisys Events

    Time (UTC) Country Event
    Tuesday, October 24, 2023

    Time (UTC)

    10:59

    Country

    US

    Event

    Q3 2023 Amedisys Inc Earnings Release
    Q3 2023 Amedisys Inc Earnings Release

    Forecast

    -

    Previous

    -
    Tuesday, February 13, 2024

    Time (UTC)

    10:59

    Country

    US

    Event

    Q4 2023 Amedisys Inc Earnings Release
    Q4 2023 Amedisys Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 2223.2 2214.11 2071.52 1955.63 1662.58
    Revenue 2223.2 2214.11 2071.52 1955.63 1662.58
    Cost of Revenue, Total 1251.43 1199.39 1185.37 1150.34 992.863
    Gross Profit 971.774 1014.72 886.15 805.296 669.715
    Total Operating Expense 2042.43 1962.2 1852.25 1778.16 1508.43
    Selling/General/Admin. Expenses, Total 754.058 711.24 668.3 607.926 501.306
    Depreciation / Amortization 24.935 30.901 28.802 18.428 13.261
    Unusual Expense (Income) 12.009 20.667 -30.22 1.47 1
    Operating Income 180.772 251.915 219.268 177.472 154.148
    Interest Income (Expense), Net Non-Operating -22.095 26.571 -6.78 -9.099 0.6
    Other, Net 1.567 1.745 -1.669 2.037 4.24
    Net Income Before Taxes 160.244 280.231 210.819 170.41 158.988
    Net Income After Taxes 117.699 210.166 185.184 127.907 120.129
    Minority Interest 0.91 -1.094 -1.576 -1.074 -0.783
    Net Income Before Extra. Items 118.609 209.072 183.608 126.833 119.346
    Net Income 118.609 209.072 183.608 126.833 119.346
    Income Available to Common Excl. Extra. Items 118.609 209.072 183.608 126.833 119.346
    Income Available to Common Incl. Extra. Items 118.609 209.072 183.608 126.833 119.346
    Diluted Net Income 118.609 209.072 183.608 126.833 119.346
    Diluted Weighted Average Shares 32.653 32.972 33.268 32.99 33.609
    Diluted EPS Excluding Extraordinary Items 3.63241 6.3409 5.51906 3.84459 3.55101
    Diluted Normalized EPS 3.96102 6.836 5.05118 4.26507 3.57349
    Total Extraordinary Items
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 552.968 556.389 562.064 557.988 557.89
    Revenue 552.968 556.389 562.064 557.988 557.89
    Cost of Revenue, Total 297.455 315.01 316.167 318.227 313.211
    Gross Profit 255.513 241.379 245.897 239.761 244.679
    Total Operating Expense 621.173 514.01 515.826 519.057 510.249
    Selling/General/Admin. Expenses, Total 212.993 194.557 193.429 188.344 187.818
    Depreciation / Amortization 4.725 4.443 5.23 5.477 6.22
    Unusual Expense (Income) 106 1 7.009 3
    Operating Income -68.205 42.379 46.238 38.931 47.641
    Interest Income (Expense), Net Non-Operating 1.231 -6.988 -5.314 -4.602 -7.616
    Other, Net 4.743 -0.682 0.412 0.491 0.331
    Net Income Before Taxes -62.231 34.709 41.336 34.82 40.356
    Net Income After Taxes -80.481 24.909 31.546 25.403 29.037
    Minority Interest 0.206 0.337 0.171 0.239 0.542
    Net Income Before Extra. Items -80.275 25.246 31.717 25.642 29.579
    Net Income -80.275 25.246 31.717 25.642 29.579
    Income Available to Common Excl. Extra. Items -80.275 25.246 31.717 25.642 29.579
    Income Available to Common Incl. Extra. Items -80.275 25.246 31.717 25.642 29.579
    Diluted Net Income -80.275 25.246 31.717 25.642 29.579
    Diluted Weighted Average Shares 32.579 32.643 32.572 32.616 32.681
    Diluted EPS Excluding Extraordinary Items -2.46401 0.7734 0.97375 0.78618 0.90508
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.34915 0.7734 0.99718 0.94296 0.97113
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 388.961 356.684 361.984 350.554 224.118
    Cash and Short Term Investments 40.54 42.694 81.808 30.294 20.229
    Cash & Equivalents 40.54 42.694 81.808 30.294 20.229
    Total Receivables, Net 309.185 287.061 259.845 241.596 192.472
    Accounts Receivable - Trade, Net 300.385 278.861 259.645 239.596 190.872
    Prepaid Expenses 11.628 10.356 10.217 8.243 7.568
    Other Current Assets, Total 27.608 16.573 10.114 70.421 3.849
    Total Assets 1976.24 1856.97 1567.2 1262.74 717.118
    Property/Plant/Equipment, Total - Net 118.882 119.692 117.159 112.904 29.449
    Property/Plant/Equipment, Total - Gross 220.246 216.629 212.183 209.041 124.921
    Accumulated Depreciation, Total -101.364 -96.937 -95.024 -96.137 -95.472
    Goodwill, Net 1287.4 1196.09 932.685 658.5 329.48
    Intangibles, Net 101.167 111.19 74.183 64.748 44.132
    Long Term Investments 60.5 53.1 14.2 35.7 35.1
    Other Long Term Assets, Total 19.336 20.212 66.987 40.339 54.839
    Total Current Liabilities 355.529 374.282 456.337 326.943 222.476
    Accounts Payable 43.735 38.217 42.674 31.259 28.531
    Accrued Expenses 296.298 323.07 343.167 285.757 192.333
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 15.496 12.995 10.496 9.927 1.612
    Total Liabilities 924.672 925.617 757.974 622.295 235.536
    Total Long Term Debt 419.42 432.075 204.511 232.256 5.775
    Long Term Debt 418.32 431.375 203.611 230.556 5.775
    Minority Interest 55 44.972 1.517 1.063 1.051
    Other Liabilities, Total 74.312 74.288 95.609 62.033 6.234
    Total Equity 1051.57 931.351 809.224 640.45 481.582
    Preferred Stock - Non Redeemable, Net 0 0 0
    Common Stock 0.038 0.038 0.038 0.037 0.036
    Additional Paid-In Capital 755.063 728.118 698.287 645.256 603.666
    Retained Earnings (Accumulated Deficit) 757.672 639.063 429.991 246.383 119.55
    Treasury Stock - Common -461.2 -435.868 -319.092 -251.241 -241.685
    Other Equity, Total 0 0.015 0.015
    Total Liabilities & Shareholders’ Equity 1976.24 1856.97 1567.2 1262.74 717.118
    Total Common Shares Outstanding 32.5183 32.51 32.8143 32.284 31.9735
    Capital Lease Obligations 1.1 0.7 0.9 1.7
    Other Current Liabilities, Total 0 60
    Deferred Income Tax 20.411
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total Current Assets 405.557 388.961 388.78 394.869 392.485
    Cash and Short Term Investments 49.436 40.54 17.956 26.566 67.834
    Cash & Equivalents 49.436 40.54 17.956 26.566 67.834
    Total Receivables, Net 294.122 296.785 302.47 305.413 293.579
    Accounts Receivable - Trade, Net 294.122 296.785 302.47 305.413 293.579
    Prepaid Expenses 18.754 11.628 17.011 15.199 17.221
    Other Current Assets, Total 43.245 40.008 51.343 47.691 13.851
    Total Assets 1946.96 1976.24 1982.13 2000.99 1908.39
    Property/Plant/Equipment, Total - Net 118.564 118.882 123.091 125.57 120.096
    Property/Plant/Equipment, Total - Gross 138.536 117.39 119.655 118.112 115.868
    Accumulated Depreciation, Total -105.183 -101.364 -102.407 -100.265 -98.573
    Goodwill, Net 1244.68 1287.4 1285.45 1289.67 1204.64
    Intangibles, Net 99.929 101.167 103.678 106.189 106.534
    Long Term Investments 58.9 60.5 61.5 65 65
    Other Long Term Assets, Total 19.33 19.336 19.623 19.686 19.639
    Total Current Liabilities 353.05 355.529 367.2 427.372 380.154
    Accounts Payable 40.017 43.735 45.527 43.509 36.621
    Accrued Expenses 286.075 296.298 309.045 371.342 331.224
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 26.958 15.496 12.628 12.521 12.309
    Other Current Liabilities, Total
    Total Liabilities 867.842 924.672 966.388 1015.34 941.634
    Total Long Term Debt 373.202 419.42 443.431 442.413 429.453
    Long Term Debt 373.202 419.42 443.431 442.413 429.453
    Minority Interest 54.231 55 53.871 53.349 53.894
    Other Liabilities, Total 64.607 74.312 85.903 86.027 75.218
    Total Equity 1079.12 1051.57 1015.74 985.646 966.758
    Preferred Stock - Non Redeemable, Net 0 0 0 0 0
    Common Stock 0.038 0.038 0.038 0.038 0.038
    Additional Paid-In Capital 758.669 755.063 750.914 743.276 736.536
    Retained Earnings (Accumulated Deficit) 782.918 757.672 725.955 700.313 670.734
    Treasury Stock - Common -462.508 -461.2 -461.168 -457.981 -440.55
    Total Liabilities & Shareholders’ Equity 1946.96 1976.24 1982.13 2000.99 1908.39
    Total Common Shares Outstanding 32.5442 32.5183 32.4795 32.4325 32.5666
    Deferred Income Tax 22.752 20.411 15.983 6.179 2.915
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line 117.699 210.166 185.184 127.907 120.129
    Cash From Operating Activities 133.283 188.893 288.952 202 223.483
    Cash From Operating Activities 24.935 30.901 28.802 18.428 13.261
    Deferred Taxes 23.377 44.582 -26.56 13.466 20.271
    Non-Cash Items 72.316 34.262 75.304 73.555 26.84
    Cash Taxes Paid 24.013 34.097 50.721 29.522 14.278
    Cash Interest Paid 27.694 5.291 6.207 9.628 3.522
    Changes in Working Capital -105.044 -131.018 26.222 -31.356 42.982
    Cash From Investing Activities -94.486 -281.607 -287.108 -352.948 -22.193
    Capital Expenditures -7.215 -6.721 -5.332 -7.888 -6.558
    Other Investing Cash Flow Items, Total -87.271 -274.886 -281.776 -345.06 -15.635
    Cash From Financing Activities -30.433 55.126 -14.977 227.209 -267.424
    Financing Cash Flow Items -5.938 -81.187 4.385 -11.465 -10.093
    Issuance (Retirement) of Stock, Net -11.199 -93.856 9.887 6.798 -173.381
    Issuance (Retirement) of Debt, Net -13.296 230.169 -29.249 231.876 -83.95
    Net Change in Cash 8.364 -37.588 -13.133 76.261 -66.134
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line 24.909 117.699 86.153 60.75 31.713
    Cash From Operating Activities 25.961 133.283 92.4 106.03 48.621
    Cash From Operating Activities 5.694 24.935 19.705 14.228 8.008
    Deferred Taxes 2.772 23.377 19.031 6.003 3.205
    Non-Cash Items 15.923 72.316 59.271 39.156 20.809
    Cash Taxes Paid 0.352 24.013 23.582 22.977 0.551
    Cash Interest Paid 6.654 27.694 9.153 4.489 1.864
    Changes in Working Capital -23.337 -105.044 -91.76 -14.107 -15.114
    Cash From Investing Activities 45.896 -94.486 -92.62 -91.587 -16.079
    Capital Expenditures -1.56 -7.215 -5.186 -3.341 -1.138
    Other Investing Cash Flow Items, Total 47.456 -87.271 -87.434 -88.246 -14.941
    Cash From Financing Activities -56.89 -30.433 -14.089 -11.448 -7.402
    Financing Cash Flow Items -2.393 -5.938 -9.047 -4.785 -4.702
    Issuance (Retirement) of Stock, Net 0.816 -11.199 -13.416 -14.688 1.071
    Issuance (Retirement) of Debt, Net -55.313 -13.296 8.374 8.025 -3.771
    Net Change in Cash 14.967 8.364 -14.309 2.995 25.14

    Amedisys Company profile

    About Amedisys Inc

    Amedisys, Inc. is a healthcare services company, which is a multi-state provider of home health, hospice, and personal care services. The Company operates through three segments: Home Health, Hospice and Personal Care. The Home Health segment delivers a range of services in the homes of individuals who may be recovering from surgery, have a chronic disability or terminal illness or need assistance with important personal tasks. The Hospice segment provides palliative care and comfort to terminally ill patients and their families. The Personal Care segment provides patients with assistance with the essential activities of daily living. The Company owns and operates approximately 320 Medicare-certified home health care centers, 180 Medicare-certified hospice care centers and approximately 14 personal-care care centers in 39 states within the United States and the District of Columbia.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, Amedisys Inc revenues increased 7% to $2.21B. Net income increased 14% to $209.1M. Revenues reflect Home Health Care segment increase of 8% to $1.35B, Hospice segment increase of 6% to $791.8M. Net income benefited from Home Health Care segment income increase of 21% to $271.7M, Other segment loss decrease of 5% to $185.5M.

    Equity composition

    Common Stock $.001 Par, 04/11, 60M auth., 30,084,676 issd., less 639,539 shs. in Treas. @ $14M. Insiders own 1.83%. 3/02, Exchangechanged from OTC Bulletin Board to NASDAQ. PO: 11/06, 3M shs. @ $41.5 per share by Raymond James. 12/06, 4-for-3 stock split.09/07, Name changed from Analytical Nursing Management.

    Industry: Home Healthcare Services

    3854 American Way Ste A
    5959 S Sherwood Forest Blvd
    BATON ROUGE
    LOUISIANA 70816
    US

    News

    EUR/USD tests key support

    EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.

    14:32, 21 September 2023
    Bank of England building

    BoE leaves rates unchanged, GBP drops further as investors look for more clarity

    The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August

    11:45, 21 September 2023
    British banknotes and coins photographed directly above. The coins are in a stack, placed on top of the banknotes.

    GBP softer after CPI surprise, JPY focused on any further hints from Ueda

    GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.

    12:42, 20 September 2023

    How to Trade The Break & Retest

    In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.

    11:59, 20 September 2023

    Cable coils near lows ahead of Fed and BoE rate decisions

    It’s a big week for Cable (GBP/USD) as both the Federal Reserve and the Bank of England are set to make crucial rate decisions.

    14:16, 19 September 2023

    FTSE 100 Technical Outlook - 18 September 2023

    In prior technical outlooks, we highlighted the importance of staying alert in sleepy markets, and last Thursday’s developments on the FTSE 100 serve as a prime illustration of this principle.

    06:55, 19 September 2023
    View of the City of London’s illuminated financial district skyline at dusk

    Market Analysis: FTSE 100 boosted by ECB rate hike end and iron ore rally

    The FTSE 100 rose over 2% on Thursday as the ECB announced no more rate hikes for now.

    13:46, 15 September 2023

    People also watch

    US100

    14,780.30 Price
    +0.570% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0039%
    Overnight fee time 21:00 (UTC)
    Spread 1.8

    BTC/USD

    26,648.10 Price
    -0.080% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 85.00

    ETH/USD

    1,598.70 Price
    +0.380% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 5.40

    Oil - Crude

    90.94 Price
    +1.510% 1D Chg, %
    Long position overnight fee 0.0349%
    Short position overnight fee -0.0568%
    Overnight fee time 21:00 (UTC)
    Spread 0.030

    Still looking for a broker you can trust?

    Join the 555.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading